Endopure Testos-Male
- Manufacturer
- Apotheca Company
- Effective date
- 2010-08-03
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 02:02:26
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS: DNA 6X, RNA 6X, Cortisol 6C, Glandula Suprarenalis 6C, Hypothalamus 6C, Pituitary 6C, Prostate 6C, Testosterone 6C, 12C, Chelidonium Majus 12C, Sabal Serrulata 12C, Thuja Occidentalis 30C.
OTC - PURPOSE SECTION
HOMEOPATHIC INDICATIONS: For the temporary relief of the following complaints; pain in spermatic cord, testicular, liver, and prostate.
WARNINGS SECTION
WARNINGS: If pregnant of breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal around neck is broken or missing. Store in a cool, dry place.
DOSAGE & ADMINISTRATION SECTION
DIRECTIONS FOR USE: 5 drops orally 2 to 3 times daily between meals. Male: Administer orally between meal, 5 drops morning between 7:30 am and 8:30 am at least 20 minutes before meals. Use evening approximately 8 to 12 pm and upon waking. Consult a physician for use in children under 12 years of age.
INACTIVE INGREDIENT SECTION
INACTIVE INGREDIENTS: Demineralized Water, 25% Ethanol
OTC - QUESTIONS SECTION
Manufactured for: Theresa Dale, Ph. D., N.D.
BioResonance Research
1237 S. Victoria Ave.
Oxnard, CA 93035
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
ENDOPURE TESTOS (FOR MEN)
Homeopathic
1 FL. OZ.
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57520-0143-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-e19d-f424-e053-dadaa90a57ce | Endopure Testos-Male |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57520-0143-1 | Endopure Testos-Male | 30 mL in 1 BOTTLE, DROPPER | LIQUID | 30 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 57520-0143 | ENDOPURE TESTOS-MALE (DNA, RNA, CORTISOL, GLANDULA SUPRARENALIS, HYPOTHALAMUS, PITRUTARY, PROSTATE, TESTOSTERONE,) LIQUID [APOTHECA COMPANY] | 3 | Legacy NDC, 1 package rows | 20100804_180cd4d7-2177-4f4c-a295-a927f3847dd1.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CHELIDONIUM MAJUS | ACTIVE INGREDIENT | 7E889U5RNN | 3 | |
| HERRING SPERM DNA | ACTIVE INGREDIENT | 51FI676N6F | 3 | |
| HYDROCORTISONE | ACTIVE INGREDIENT | WI4X0X7BPJ | 3 | |
| SACCHAROMYCES CEREVISIAE RNA | ACTIVE INGREDIENT | J17GBZ5VGX | 3 | |
| SAW PALMETTO | ACTIVE INGREDIENT | J7WWH9M8QS | 3 | |
| SUS SCROFA ADRENAL GLAND | ACTIVE INGREDIENT | 398IYQ16YV | 3 | |
| SUS SCROFA HYPOTHALAMUS | ACTIVE INGREDIENT | N6R0856Z79 | 3 | |
| SUS SCROFA PITUITARY GLAND | ACTIVE INGREDIENT | E8S87O660T | 3 | |
| SUS SCROFA PROSTATE | ACTIVE INGREDIENT | O6UD3347K2 | 3 | |
| TESTOSTERONE | ACTIVE INGREDIENT | 3XMK78S47O | 3 | |
| THUJA OCCIDENTALIS LEAFY TWIG | ACTIVE INGREDIENT | 1NT28V9397 | 3 | |
| CHELIDONIUM MAJUS | ACTIVE MOIETY | 7E889U5RNN | 3 | |
| HERRING SPERM DNA | ACTIVE MOIETY | 51FI676N6F | 3 | |
| HYDROCORTISONE | ACTIVE MOIETY | WI4X0X7BPJ | 3 | |
| SACCHAROMYCES CEREVISIAE RNA | ACTIVE MOIETY | J17GBZ5VGX | 3 | |
| SAW PALMETTO | ACTIVE MOIETY | J7WWH9M8QS | 3 | |
| SUS SCROFA ADRENAL GLAND | ACTIVE MOIETY | 398IYQ16YV | 3 | |
| SUS SCROFA HYPOTHALAMUS | ACTIVE MOIETY | N6R0856Z79 | 3 | |
| SUS SCROFA PITUITARY GLAND | ACTIVE MOIETY | E8S87O660T | 3 | |
| SUS SCROFA PROSTATE | ACTIVE MOIETY | O6UD3347K2 | 3 | |
| TESTOSTERONE | ACTIVE MOIETY | 3XMK78S47O | 3 | |
| THUJA OCCIDENTALIS LEAFY TWIG | ACTIVE MOIETY | 1NT28V9397 | 3 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 3 |
Products#
Every source-derived product name is available through these pages.
- Endopure Testos-Male
- DNA, RNA, Cortisol, Glandula suprarenalis, Hypothalamus, Pitrutary, Prostate, Testosterone,
- HERRING SPERM DNA
- SACCHAROMYCES CEREVISIAE RNA
- HYDROCORTISONE
- SUS SCROFA HYPOTHALAMUS
- SUS SCROFA PITUITARY GLAND
- SUS SCROFA PROSTATE
- TESTOSTERONE
- CHELIDONIUM MAJUS
- SAW PALMETTO
- THUJA OCCIDENTALIS LEAFY TWIG
- SUS SCROFA ADRENAL GLAND
- WATER
- ALCOHOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 57520-0143 | 57520-0143-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| HERRING SPERM DNA | 51FI676N6F | ACTIB |
| SACCHAROMYCES CEREVISIAE RNA | J17GBZ5VGX | ACTIB |
| HYDROCORTISONE | WI4X0X7BPJ | ACTIB |
| SUS SCROFA HYPOTHALAMUS | N6R0856Z79 | ACTIB |
| SUS SCROFA PITUITARY GLAND | E8S87O660T | ACTIB |
| SUS SCROFA PROSTATE | O6UD3347K2 | ACTIB |
| TESTOSTERONE | 3XMK78S47O | ACTIB |
| CHELIDONIUM MAJUS | 7E889U5RNN | ACTIB |
| SAW PALMETTO | J7WWH9M8QS | ACTIB |
| THUJA OCCIDENTALIS LEAFY TWIG | 1NT28V9397 | ACTIB |
| SUS SCROFA ADRENAL GLAND | 398IYQ16YV | ACTIB |
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 02d86a85-bd06-4f30-b0f4-76b3f68f5af2 | 180cd4d7-2177-4f4c-a295-a927f3847dd1 | 2010-08-03 | Warnings | 02d86a85-bd06-4f30-b0f4-76b3f68f5af2 180cd4d7-2177-4f4c-a295-a927f3847dd1 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
